Category: Health & Medicines > Medicines > Voglibose
Country/Region: India State/Province: Delhi
Main Products: Capecitabine, Lornoxicam, Pemetrexed Disodium, Ropivacaine, Bupivacaine
Business Type: Exporter, Services
Year Established: 2019
Employees: 5 - 10 People
Plant Area: 1,000-3,000 square meters
Main Markets: South America 11% Africa 8% Eastern Asia 9% Domestic Market 10% North America 10% Eastern Europe 9% Southern Europe 10% Mid East 10% Northern Europe 10% Oceania 13%
Trade Capacity: FOB, CFR, DEQ
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: ambernath
Annual Revenue: US$50 Million - US$100 Million
Total Revenue: US$5 Million - US$10 Million
Export Revenue: Below US$1 Million
Annual Output: confidential
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 71% - 80%
Payment Modes: USD, AUD, GBP
Lead Time: 34 days
Import/Export Mode: LLC (Limited Liability Corp)